FDA Approved: RELISTOR — Original Application (Salix Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved RELISTOR (methylnaltrexone bromide) through its original application for the treatment of opioid-induced constipation in patients on opioid therapy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-induced Constipation

Drugs mentioned

• RELISTOR (methylnaltrexone)

Snippet

ORIG AP for RELISTOR (METHYLNALTREXONE BROMIDE)